Figure and Table | Claims-based Analysis of Zoster Vaccine Effectiveness against Incident Herpes Zoster: The VENUS Study

Table 1. Characteristics of Participants.

	Unvaccinated	RZV-vaccinated	Unvaccinated	VVL-vaccinated
n	294	294	197	197
Mean follow-up duration (months) [SD]	5.3 [1.6]	5.5 [1.6]	5.1 [2.3]	5.3 [2.3]
Women, n (%)	199 (67.7)	199 (67.7)	143 (72.6)	143 (72.6)
Mean age (years) [SD]	74.9 [7.5]	74.9 [7.5]	74.7 [6.7]	74.7 [6.7]

Table 2. Associations Between Zoster Vaccination and Incident HZ.

	Unvaccinated	RZV-vaccinated	Mid-p	Unvaccinated	VVL-vaccinated	Mid-p
Incident HZ, n (%)	5 (1.7)	0 (0.0)	0.06	4 (2.0)	2 (1.0)	0.22
Mean duration until HZ occurrence (months) [SD]	3.4 [2.9]	NA		4.3 [1.7]	6 [2.8]